참여 물질
| 역할 | 이름 | HCID | 투입량 |
|---|
| 반응물 | Guanidine | HCID 3520 | — |
| 반응물 | Ethyl Nitrite | HCID 8026 | — |
| 반응물 | Thiourea | HCID 2723790 | — |
| 반응물 | 2-Amino-5-(2-aminoethyl)thiomethylthiazole | HCID 21410003 | — |
| 생성물 | 2-((Thiazol-5-ylmethyl)thio)ethanamine | HCID 12923407 | — |
반응 단계
Conversion of the compounds of formula II to the pharmacologically active guanidine and thiourea products is accomplished in a variety of ways. When R2 is --SCH2CH2NH2, the 2-amino group of the 2-amino-5-(2-aminoethyl)thiomethylthiazole is removed, for example by reaction with ethylnitrite, to give the corresponding 5-(2-aminoethyl)thiomethylthiazole compound which is then treated with methyl isothiocyanate to give the corresponding N-methyl-N'-[2-(4-R1 -thiazolylmethylthio)ethyl]thioureas. Reaction of the same 5-(2-aminoethyl)thiomethylthiazole compound with N-cyano-N',S-dimethylisothiourea gives the corresponding N-cyano-N'-methyl-N"-[2-(4-R1 -thiazolylmethylthio)ethyl]guanidines. The guanidine products are also prepared by reaction of the 5-(2-aminoethyl)thiomethylthiazole with dimethyl-N-cyanoimidodithiocarbonate and subsequently reacting the resulting N-cyano-N'-[2-(4-R1 -thiazolylmethylthio)ethyl]-S-methylisothiourea with methylamine.
출처 및 근거
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| 특허 번호 | US04049669 |
|---|
| 출처 데이터셋 | uspto-grants-1977_09 |
|---|
| ORD ID | ord-6838ee9de1b1482eb0e4047a04d6cbb0 |
|---|
| 출처 메모 | uspto-grants-1977_09 |
|---|